Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on ASEANA PROPERTIES LTD. We currently have 1 research reports from 1 professional analysts.
|28Feb17 07:00||RNS||Quarterly Investor Update and Total Voting Rights|
|10Jan17 17:51||RNS||Director/PDMR Shareholding|
|05Jan17 16:22||RNS||Result of Tender Offer and Total Voting Rights|
|04Jan17 10:45||RNS||Result of EGM|
|23Dec16 07:00||RNS||Publication of Q3 2016 Corporate Presentation|
|13Dec16 09:15||RNS||Posting of Circular: Tender Offer & Notice of EGM|
|09Dec16 09:47||RNS||Quarterly Investor Update|
Frequency of research reports
Research reports on
ASEANA PROPERTIES LTD
ASEANA PROPERTIES LTD
N+1 Singer - Aseana Properties - Q2 investor update
26 Aug 16
Aseana Properties (ASPL) is conducting an orderly asset disposal, following the shareholder vote to cease making new investments. It has recently sold its entire position in Aloft Kuala Lumpur Sentral Hotel for US$104.2m and has utilised the proceeds to reduce its borrowings, and is currently in negotiations with its lenders to allow a capital distribution.
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
Small Cap Breakfast
21 Mar 17
First Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march. Tufton Oceanic Assets- The Company intends to invest in a diversified portfolio of second hand commercial sea-going vessels where the Investment Manager believes that an attractive opportunity exists in shipping. $150m raise. Admission 3 April.